Search research articles
Contact Us
Filters
Showing results (71-80 of 210) with videos related to
Page
of 21
Sort By:
Journal of the American Academy of Dermatology
|
July 30, 1999
Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides
C T Chui, R T Hoppe, S Kohler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 1998
What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
M P Mac Manus, C A Rainer Bowie, R T Hoppe
Cancer
|
November 1, 1977
The long term effects of radiation of T and B lymphocytes in the peripheral blood after regional irradiation
R T Hoppe, Z Y Fuks, S Strober, et al.
Transplantation Proceedings
|
December 1, 1979
Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease
E G Engleman, C Benike, R T Hoppe, et al.
Cancer
|
August 1, 1987
Extracutaneous mycosis fungoides
C J Merlo, R T Hoppe, E Abel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy
M J Crnkovich, K Leopold, R T Hoppe, et al.
Journal of Cutaneous Pathology
|
April 1, 1994
Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype
G S Wood, A Edinger, R T Hoppe, et al.
Radiology
|
January 1, 1989
Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management
G D Pond, R A Castellino, S Horning, et al.
Archives of Dermatology
|
July 1, 1987
PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study
E A Abel, E Sendagorta, R T Hoppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease
M Roach, D S Kapp, S A Rosenberg, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 210) with videos related to
Sort By:
Page
of 21
Journal of the American Academy of Dermatology
|
July 30, 1999
Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides
C T Chui, R T Hoppe, S Kohler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 1998
What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
M P Mac Manus, C A Rainer Bowie, R T Hoppe
Cancer
|
November 1, 1977
The long term effects of radiation of T and B lymphocytes in the peripheral blood after regional irradiation
R T Hoppe, Z Y Fuks, S Strober, et al.
Transplantation Proceedings
|
December 1, 1979
Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease
E G Engleman, C Benike, R T Hoppe, et al.
Cancer
|
August 1, 1987
Extracutaneous mycosis fungoides
C J Merlo, R T Hoppe, E Abel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy
M J Crnkovich, K Leopold, R T Hoppe, et al.
Journal of Cutaneous Pathology
|
April 1, 1994
Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype
G S Wood, A Edinger, R T Hoppe, et al.
Radiology
|
January 1, 1989
Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management
G D Pond, R A Castellino, S Horning, et al.
Archives of Dermatology
|
July 1, 1987
PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study
E A Abel, E Sendagorta, R T Hoppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease
M Roach, D S Kapp, S A Rosenberg, et al.
Page
of 21